Thursday
SESSION 43: NEW OR IMPROVED TECHNOLOGIES FOR VASCULAR TREATMENT
SESSION 43 SCHEDULE
6:55 AM - 7:00 AM Advantages Of A Fully Self-Expanding Bioabsorbable Stent Scaffold In The Treatment Of SFA Disease: Results Of The STANCE Study
  Presenter(s):Andrew Holden, MBChB  
7:01 AM - 7:06 AM Results With The Next Generation Dual Component (Nitinol And PTFE) Stent (Tigris Stent From Gore): Concept And Early Results
  Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR  
7:07 AM - 7:12 AM Diagnosis Of Flow-Limiting Stenosis And Plaque Vulnerability In One Non-Invasive Test: It Will Be Possible And Clinically Useful For Evaluating Peripheral Arterial Stenoses
  Presenter(s):Christopher K. Zarins, MD  
7:13 AM - 7:18 AM Update On Biodegradable Stents In The Coronary Position And Elsewhere: Impact Of Fractures On Thrombosis And Restenosis: Why They May Be Important
  Presenter(s):Ron Waksman, MD  
7:19 AM - 7:24 AM System For Reducing Radiation Exposure While Maintaining Image Quality During Interventional Procedures
  Presenter(s):Olivier H.J. Koning, MD, PhD  
7:25 AM - 7:30 AM What’s New In Drug Eluting Stent (DES) Technology And What Difference Will It Make
  Presenter(s):Ron Waksman, MD  
7:31 AM - 7:36 AM Reentry Jugular Access Device
  Presenter(s):Mark H. Wholey, MD / Kumar Pilai, MD  
7:37 AM - 7:43 AM Panel Discussion
END OF SESSION 43
previous next